FDA Commissioner Scott Gottlieb, MD, said his administration is working on an updated “new regulatory framework” to promote the use of artificial intelligence (AI) in healthcare, and he expects medical imaging to be at the forefront of AI-based healthcare devices, according to a report published by The Hill.